Coronary Guidewires Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Powered by 
All the vital news, analysis, and commentary curated by our industry experts.
Coronary Guidewires Pipeline Market Report Overview
A coronary guidewire is used to navigate catheters during angiography and Percutaneous Coronary Interventions (PCIs). The guidewire has an elongated body which provides flexibility and a distal tip. A coronary guidewire is of two types- Standard Coronary Guidewires and Fractional Flow Reserve (FFR) Coronary Guidewires.
The Coronary Guidewires pipeline market research report provides comprehensive information about the Coronary Guidewires pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Coronary Guidewires Pipeline Market Segmentation by Territories
Some of the key territories in the Coronary Guidewires pipeline market are the US, China, Europe, Australia, Canada, Japan, and the UK. In 2023, the US has the highest number of pipeline products.
Coronary Guidewires Pipeline Market Analysis, by Territories, 2023 (%)
For more territory insights into the Coronary Guidewires pipeline market, download a free report sample
Coronary Guidewires Pipeline Market Segmentation by Regulatory Paths
The key regulatory paths in the Coronary Guidewires pipeline market are 510(k), CE, NMPA, PMA, Shonin, TGA, UKCA, and MDL. In 2023, 510(k) was the most followed regulatory path for pipeline products.
Coronary Guidewires Pipeline Market Analysis, by Regulatory Paths, 2023 (%)
For more regulatory paths into the Coronary Guidewires pipeline market, download a free report sample
Coronary Guidewires Pipeline Market- Competitive Landscape
Some of the key companies in the Coronary Guidewires pipeline market are Abbott Vascular Inc, APT Medical Inc, Bioscan Technologies Inc., Boston Scientific Corp, Cardiovascular Systems Inc, CorMetrics LLC, Echopoint Medical Ltd, ENDOMATERIALS, Georgia Institute of Technology, and Guided Interventions, LLC.
Abbott Vascular Inc: Headquartered in Santa Clara, California, the US, Abbott Vascular Inc (Abbott Vascular), formerly known as Perclose, Inc., a subsidiary of Abbott Laboratories, is a medical device company that develops manufactures and markets cardiovascular devices. The company offers coronary intervention, peripheral intervention, and structural heart products. Its coronary intervention products include bleedback control valve, coronary dilatation catheters, coronary drug eluting stents, coronary guide wires, and others.
APT Medical Inc: APT Medical Inc is a supplier and manufacturer of EP and vascular intervention medical devices. The company is headquartered in Nanshan District, Shenzhen, China.
Bioscan Technologies Inc.: Headquartered in Yokneam, Israel, Bio Scan Technologies Inc. (BioScan) is a medical equipment manufacturing company which is engaged in the development of diagnostic imaging products for the cardiovascular markets. The company product are used in angioplasty procedures and also provides online information on lumen and vessel wall dimensions. The major product, LightWire, is an opto-acoustic coronary imaging guidewire based on its proprietary optical ultrasonic technology used as diagnostic and guidance tool in coronary and peripheral angioplasty procedures.
Coronary Guidewires Pipeline Market Report Overview
| Key Territories | The US, China, Europe, Australia, Canada, Japan, and the UK |
| Key Regulatory Paths | 510(k), CE, NMPA, PMA, Shonin, TGA, UKCA, and MDL |
| Leading Companies | Abbott Vascular Inc, APT Medical Inc, Bioscan Technologies Inc., Boston Scientific Corp, Cardiovascular Systems Inc, CorMetrics LLC, Echopoint Medical Ltd, ENDOMATERIALS, Georgia Institute of Technology, and Guided Interventions, LLC |
Segments Covered in the Report
Coronary Guidewires Pipeline Market Territories Outlook
- The US
- China
- Europe
- Australia
- Canada
- Japan
- The UK
Coronary Guidewires Pipeline Market Regulatory Paths Outlook
- 510(k)
- CE
- NMPA
- PMA
- Shonin
- TGA
- UKCA
- MDL
Scope
- Extensive coverage of the Coronary Guidewires under development.
- Reviews the details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates.
- Reviews of major players involved in the pipeline product development.
- Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and the number of trials of the major Coronary Guidewires pipeline products.
- Review of Recent Developments in the segment / industry.
Reasons to Buy
The Coronary Guidewires report enables you to:
- Access significant competitor information, analysis, and insights to improve your R&D strategies.
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage.
- Identify and understand important and diverse types of Coronary Guidewires under development.
- Formulate market-entry and market expansion strategies.
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
APT Medical Inc
Bioscan Technologies Inc.
Boston Scientific Corp
Cardiovascular Systems Inc
CorMetrics LLC
Echopoint Medical Ltd
ENDOMATERIALS
Georgia Institute of Technology
Guided Interventions, LLC
Infrared Sciences Corp
Koninklijke Philips NV
MaRVis Technologies GmbH
Microbot Medical Ltd
MicroPort Scientific Corp
NewMed Medical Co Ltd
Nirtek Pty Ltd
Opsens Inc
OVALUM Ltd
SoundBite Medical Solutions Inc
St. Jude Medical LLC
Terumo Corp
Terumo Interventional Systems
The Cleveland Clinic Foundation
Three Rivers Cardiovascular Systems Inc
Transmural systems LLC
University of Illinois at Chicago
Vasostar Ltd.
Table of Contents
Table
Figures
Frequently asked questions
-
Which are the key territories in the Coronary Guidewires pipeline market?
Some of the key territories in the Coronary Guidewires pipeline market are the US, China, Europe, Australia, Canada, Japan, and the UK.
-
What are the key regulatory paths in the Coronary Guidewires pipeline market?
The key regulatory paths in the Coronary Guidewires pipeline market are 510(k), CE, NMPA, PMA, Shonin, TGA, UKCA, and MDL.
-
What are coronary guidewires used for?
Coronary guidewires are used to navigate catheters during angiography and Percutaneous Coronary Interventions (PCIs).
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Sample Report
Coronary Guidewires Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:
- Assess the relevance of the report
- Evaluate the quality of the report
- Justify the cost
Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.
Related reports
View more Coronary Guidewires reports
